Davita Inc. Stock
Davita Inc. Stock
Davita Inc. gained 0.410% compared to yesterday.
Our community is currently high on Davita Inc. with 5 Buy predictions and 1 Sell predictions.
On the other hand, the target price of 146 € is below the current price of 146.95 € for Davita Inc., so the potential is actually -0.65%.
Our community identified positive and negative aspects for Davita Inc. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Davita Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Davita Inc. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Davita Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Davita Inc. | 0.410% | -0.474% | 10.780% | 59.278% | 55.634% | 43.646% | 171.727% |
Amn Healthcare Svs | -3.880% | -3.883% | -11.607% | -49.554% | -40.896% | -57.647% | -22.292% |
Premier Inc. | -1.080% | -0.543% | 0.549% | - | - | - | - |
Ensign Group Inc. | -0.730% | -1.449% | 5.426% | 54.545% | 32.039% | - | - |
Comments
DaVita Inc. (NYSE: DVA) had its price target raised by analysts at UBS Group AG from $169.00 to $175.00. They now have a "buy" rating on the stock.
Show more
Ratings data for DVA provided by MarketBeat
DaVita Inc. (NYSE: DVA) had its price target raised by analysts at Bank of America Co. from $139.00 to $145.00. They now have an "underperform" rating on the stock.
Show more
Ratings data for DVA provided by MarketBeat
DaVita Inc. (NYSE: DVA) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for DVA provided by MarketBeat